Abstract
Neurodegenerative diseases are associated with progressive neuronal injury, mitochondrial dysfunction, and impaired cellular quality control mechanisms. Urolithin A (UA), a gut microbiota-derived metabolite, has demonstrated potential neuroprotective properties. However, its effects on neurotoxicity-associated cellular responses remain incompletely understood. This study investigated the protective effects of UA against 1-methyl-4-phenylpyridinium (MPP+)-induced cellular injury in retinoic acid-differentiated SH-SY5Y cells. Cell viability was assessed using the MTT assay, while amyloid-beta (Aβ), LC3B, Tom20, and Parkin were evaluated using immunofluorescence microscopy. Mitochondrial staining was examined using MitoTracker. UA treatment improved cell viability following MPP+ exposure and reduced Aβ immunoreactivity. Furthermore, UA increased LC3B-positive puncta, altered Parkin localization, and partially restored MitoTracker fluorescence intensity in MPP+-treated cells. These findings suggest that UA may influence autophagy- and mitophagy-associated cellular responses. However, the observed changes do not directly establish enhanced autophagic or mitophagic flux, Aβ clearance, or restoration of mitochondrial function. Collectively, this study provides preliminary evidence that UA attenuates MPP+-induced cellular injury and modulates markers associated with cellular and mitochondrial quality control. Further functional and mechanistic investigations are necessary to clarify its neuroprotective mechanisms and therapeutic potential.